/ mediates m6A modification of to regulate PDGF-BB-induced airway smooth muscle cell function.

Background: Increased proliferation and migration of abnormal airway smooth muscle cells (ASMCs) are significantly associated with asthma. This study aimed to investigate the effects of methyltransferase-like 14 (), YTH domain-containing family Protein 1 (), and polypyrimidine tract-binding protein 1 () on platelet-derived growth factor-BB (PDGF-BB)-treated ASMCs.

Methods: ASMCs were treated with PDGF-BB to mimic cell remodeling. A cell counting kit-8 (CCK-8) assay was performed to detect cell viability. Cell proliferation was detected by 5-Ethynyl-2'-deoxyuridine (EdU) assay. The migration and invasion of cells were measured by wound healing assay and transwell assay. Interleukin 1β (IL-1β) and tumor necrosis factor-α (TNF-α) were evaluated using ELISA kits. The oxidative stress markers reactive oxygen species (ROS) and malondialdehyde (MDA) levels were evaluated using corresponding kits. RT-qPCR and western blotting were utilized to assess mRNA and protein expression. The m6A level was determined using methylated RNA immunoprecipitation (MeRIP) assay. RNA Immunoprecipitation (RIP) assay was used to evaluate the binding of or to mRNA. The binding of to was quantified by dual-luciferase assay.

Results: PDGF-BB treatment promoted ASMCs proliferation, migration, invasion, secretion of IL-1β and TNF-α, increased MDA and ROS levels, and promoted macrophage polarization. Knockdown of attenuated PDGF-BB-induced proliferation, migration, invasion, inflammation, oxidative stress, and macrophage polarization in ASMCs. / facilitated the m6A methylation modification of . Elevated expression nullified the influence of increased expression on PDGF-BB-stimulated ASMCs. influenced the expression of nuclear factor kappa B (NF-κB) pathway-associated proteins .

Conclusion: The m6A methylation of , mediated by /, played a critical role in modulating the functional behavior of ASMCs induced by PDGF-BB during the progression of asthma.